Consideration of Gender on Hormone Therapy Management
Copyright © 2023 Elsevier Inc. All rights reserved..
Hormone therapy is a common treatment method for adult males, females, and transgender and gender-diverse individuals. Both men, women, and transgender and gender-diverse people may use hormone therapy at some point in their lives. There are notable differences and similarities in risk factors related to hormone therapy use based on genetics, sex, gender, personal history, and the type of hormone therapy used. Provider awareness in gender-inclusive hormone therapy management with the consideration of nonmodifiable and modifiable risk factors, prevention of complications, and monitoring parameters is essential in clinical practice.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
The Nursing clinics of North America - 58(2023), 4 vom: 13. Dez., Seite 627-637 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Morgan, Lindsay L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Female |
|---|
| Anmerkungen: |
Date Completed 01.11.2023 Date Revised 01.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cnur.2023.06.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363259678 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363259678 | ||
| 003 | DE-627 | ||
| 005 | 20231226092948.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cnur.2023.06.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1210.xml |
| 035 | |a (DE-627)NLM363259678 | ||
| 035 | |a (NLM)37833004 | ||
| 035 | |a (PII)S0029-6465(23)00048-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Morgan, Lindsay L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Consideration of Gender on Hormone Therapy Management |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2023 | ||
| 500 | |a Date Revised 01.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a Hormone therapy is a common treatment method for adult males, females, and transgender and gender-diverse individuals. Both men, women, and transgender and gender-diverse people may use hormone therapy at some point in their lives. There are notable differences and similarities in risk factors related to hormone therapy use based on genetics, sex, gender, personal history, and the type of hormone therapy used. Provider awareness in gender-inclusive hormone therapy management with the consideration of nonmodifiable and modifiable risk factors, prevention of complications, and monitoring parameters is essential in clinical practice | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Gender diverse | |
| 650 | 4 | |a Gender-inclusive | |
| 650 | 4 | |a Hormone therapy | |
| 650 | 4 | |a Hormone therapy similarities | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a Transgender | |
| 650 | 7 | |a Hormones |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t The Nursing clinics of North America |d 1966 |g 58(2023), 4 vom: 13. Dez., Seite 627-637 |w (DE-627)NLM000043672 |x 1558-1357 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2023 |g number:4 |g day:13 |g month:12 |g pages:627-637 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cnur.2023.06.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 58 |j 2023 |e 4 |b 13 |c 12 |h 627-637 | ||